|
Transcripts Owing to difficulties in transcription, S.T.O.P. is unable to provide the text of what Dr. Ruggenenti said at the conference. However, he presented extensive data from studies done in Europe, supporting that ACE inhibitors could not only slow down progression to end stage renal failure, but in some cases might actually reverse it. The ENCHLOSE network was seeking additional funds to do follow-on studies. |
| Copyright 2000 | Reprint Policy | |
| Last Modified: September 1, 2001 |